Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, announced today that President and CEO Ryan Ashton and CFO Jeffrey Rona will speak at three upcoming investment conferences in New York City, including:

  • Sidoti Emerging Growth Conference on September 2 at 2:50pm E.T.
  • Rodman & Renshaw 17th Annual Global Investment Conference on September 9 at 9:10am E.T.
  • SeeThru Equity Fall Microcap Investor Conference on September 10 at 10:00am E.T.

The Company’s presentations from the Sidoti and Rodman & Renshaw events will be available on the Investors Relations section of the Company website at www.gbscience.com beginning 15 minutes before the presentation time and will be archived for 90 days.

About Great Basin Scientific

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company’s website at www.gbscience.com.